Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$406K Buy
1,614
+13
+0.8% +$2.8K 0.07% 75
2026
Q1
$348K Buy
1,601
+504
+46% +$112K 0.06% 75
2025
Q4
$251K Buy
1,097
+175
+19% +$39.9K 0.05% 84
2025
Q3
$213K Buy
+922
New +$188K 0.04% 88

Other funds holding ABBV

Rockport Wealth's ABBV Position: Q2 2026 in Review

Rockport Wealth increased its AbbVie (ABBV) stake by 0.81% in Q2 2026, buying an estimated $2.8K and bringing the position to 1,614 shares worth $406K. The position accounts for 0.07% of the portfolio, ranked #75.

Rockport Wealth first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 2,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rockport Wealth held 1,614 shares of AbbVie worth $406K as of Q2 2026.
  • Rockport Wealth bought 13 AbbVie shares in Q2 2026, an estimated $2.8K.
  • AbbVie made up 0.07% of Rockport Wealth's portfolio in Q2 2026, its #75 holding.
  • Rockport Wealth first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
  • 2,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rockport Wealth's 13F filing for Q2 2026, filed 27 Jul 2026.